Clinical Trial Update: Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 pediatric trial evaluating beta blockers for pulmonary arterial hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Beta blockers (class) (beta-adrenergic blockers)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Pulmonary Arterial Hypertension | Phase 1, Phase 2 | Status: WITHDRAWN